跳至主要内容
临床试验/RBR-2t56nz
RBR-2t56nz已完成未知

Double Blind Randomized Trial for L-arginine Effectineness study as a coadjuvante therapeutic protocol in the treatment of Sickle Cell Anemia

niversidade Federal do Ceará0 个研究点开始时间: 2017年10月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

入选标准

  • Adult patients volunteers between 18 and 80 years with sickle cell anemia; both genders; in use of hydroxiurea from 500mg per day; baseline

排除标准

  • Patients who do not have sickle cell anemia; Patients who refuse to participate in the study not signing the ethic term; those who have had transfusional therapy in the last three months; patients using iron chelator and antioxidant vitamins; patients smokers and drinkers; pregnant or with diabetes mellitus or with some picture of renal or hepatic insufficiency

研究者

发起方
niversidade Federal do Ceará

相似试验